Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6140
|
pubmed:dateCreated |
1978-12-27
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-1447
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
801
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:279388-Adolescent,
pubmed-meshheading:279388-Adult,
pubmed-meshheading:279388-Aged,
pubmed-meshheading:279388-Humans,
pubmed-meshheading:279388-Leukemia, Myeloid, Acute,
pubmed-meshheading:279388-Middle Aged,
pubmed-meshheading:279388-Piperazines,
pubmed-meshheading:279388-Razoxane,
pubmed-meshheading:279388-Remission, Spontaneous
|
pubmed:year |
1978
|
pubmed:articleTitle |
Razoxane in treatment of acute myeloid leukaemia.
|
pubmed:publicationType |
Journal Article
|